跳至主要内容
临床试验/NCT02515760
NCT02515760进行中(未招募)不适用

Tumor-specific Effector T Cells in Non-small Cell Lung Cancer

University Hospital Heidelberg2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
120
试验地点
2
主要终点
Frequencies of tumor-specific T cells

研究概览

简要总结

Non-small cell lung cancer is characterized by aggressive growth and treatment resistance. New approaches include immunotherapeutic strategies but spontaneous immune responses against tumor antigens remain unclear. The aim of this study is to characterize localization and frequencies of spontaneously induced memory T cells specific for a panel of tumor-associated antigens in peripheral blood and bone marrow of non-small cell lung cancer patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with histology proven non-small cell lung cancer or a lesion suspicious of non-small cell lung cancer (lung cancer group)
  • Healthy donors (control group)
  • written informed consent

排除标准

  • Autoimmune disease
  • Patients receiving immunomodulatory drugs, e.g. tacrolimus
  • Prior malignancy
  • Pregnancy

结局指标

主要结局

Frequencies of tumor-specific T cells

时间窗: 2 weeks postoperative

% of all T cells

次要结局

  • Tumor-specific T cells location determined by Enzyme Linked Immuno Spot Assay (ELISPOT) analysis of peripheral blood and bone marrow samples from the same patient(2 weeks postoperative)
  • Long-term survival(5 years postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. med. Seyer Safi

PD Dr. med. Seyer Safi

University Hospital Heidelberg

研究点 (2)

Loading locations...

相似试验